Parmax Pharma Ltd — Board Meeting, 17-11-2025: Board Meeting
17-11-2025 | 09:16 pm
17-11-2025 | 09:16 pm
Parmax Pharma's board approved the financial results for the quarter and half-year. The company posted a net profit of ₹2.08 Cr for Q2 and ₹2.84 Cr for H1 ended Sep 30. Auditors highlighted non-provision of depreciation on certain unused assets.
No comments yet. Be the first to comment!
